electroCore to Announce Third Quarter 2022 Financial Results on November 3
27 Outubro 2022 - 9:00AM
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic
medicine company, announced today that it will report financial
results for the third quarter ended September 30, 2022, after the
close of the market on Thursday, November 3, 2022. Management will
host a conference call and webcast at 4:30 PM EDT to discuss the
financial results and answer questions.
Thursday, November 3, 2022, 4:30 PM EDT
Domestic: 877-269-7756 International: 201-689-7817 Conference ID:
13733010 Webcast: electroCore Earnings Webcast
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine company dedicated to
improving patient outcomes through its non-invasive vagus nerve
stimulation therapy platform, initially focused on the treatment of
multiple conditions in neurology. The company's current indications
are the preventive treatment of cluster headache and migraine, the
acute treatment of migraine and episodic cluster headache, the
acute and preventive treatment of migraines in adolescents, and
paroxysmal hemicrania and hemicrania continua in adults.
For more information, visit www.electrocore.com.
Contact: Rich Cockrell CG Capital 404-736-3838
ecor@cg.capital
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024